A Case Report: Rare Case of Gallbladder Carcinoma Misdiagnosed as Pancreatic Adenocarcinoma in a 5 Week Pregnant Female Patient
DOI:
https://doi.org/10.38179/ijcr.v1i1.1Keywords:
Gallbladder carcinoma, rare case, misdiagnosis, pregnant patient, case reportAbstract
Background: Gallbladder carcinoma is the fifth most common gastrointestinal malignant neoplasm and the most frequent malignant tumor of the biliary tract. It has a poor prognosis, with a 50% 1-year survival rate for patients with stage 1 disease. Unfortunately, this rare disease usually presents at a more advanced stage, with a 5-year survival rate of only 5%.
Case Presentation: The present study describes a case of gallbladder adenocarcinoma presenting in a 34 years old female patient of 5 weeks gestational age in the form of a right upper quadrant pain radiating to the back. The patient had no known history of gallstones, cholecystitis, chronic H. pylori infection or other risk factors. Being 5 weeks pregnant, imaging was first restricted to an abdominopelvic ultrasound and MRI without contrast, which revealed a peri-duodenal-pancreatic mass. There was a high suspicion of pancreatic tumor after an endoscopic ultrasound FNA had revealed an adenocarcinoma, on pathology. It was only after opting for a Whipple procedure that pathology revealed that the primary tumor was a gallbladder adenocarcinoma with an 8 cm peri-pancreatic mass, represented by a poorly-differentiated adenocarcinoma, that probably developed within a lymph node. Fortunately, the patient presented early and resection was successfully performed. She is following-up with oncology for chemotherapy.
Conclusions: The purpose of this report is to highlight a rare disease occurring in a young pregnant patient, and how it was misdiagnosed as a pancreatic adenocarcinoma due to the involvement of the peri-pancreatic lymph node, the results of the EUS guided FNA, and of the preoperative imaging studies.
References
Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 2014;6:99‐109. Published 2014 Mar 7. https://doi.org/10.2147/CLEP.S37357 PMid:24634588 PMCid:PMC3952897
Shamseddine A, Saleh A, Charafeddine M, Seoud M, Mukherji D, Temraz S, Sibai AM. Cancer trends in Lebanon: a review of incidence rates for the period of 2003-2008 and projections until 2018. Popul Health Metr. 2014 Mar 4;12(1):4. https://doi.org/10.1186/1478-7954-12-4 PMid:24593777 PMCid:PMC3996020
Kanthan R, Senger JL, Ahmed S, Kanthan SC. Gallbladder Cancer in the 21st Century. J Oncol. 2015;2015:967472. https://doi.org/10.1155/2015/967472. Epub 2015 Sep 1. PMid:26421012 PMCid:PMC4569807
Arroyo GF, Gentile A, Parada LA. Gallbladder cancer: South American experience. Chin Clin Oncol. 2016 Oct;5(5):67. https://doi.org/10.21037/cco.2016.10.01 PMid:27829280
Shaffer EA. Gallbladder cancer: the basics. Gastroenterol Hepatol (N Y). 2008 Oct;4(10):737-41. PMid: 21960896; PMCid: PMC3104187.
Maharaj R, Cave C, Sarran K, Bascombe N, Dan D, Greaves W, Warner WA. A case report of the clear cell variant of gallbladder carcinoma. Int J Surg Case Rep. 2017;32:36-39. https://doi.org/10.1016/j.ijscr.2017.01.020. Epub 2017 Jan 12. PMid:28222323 PMCid:PMC5318351.
Gourgiotis S, Kocher HM, Solaini L, Yarollahi A, Tsiambas E, Salemis NS. Gallbladder cancer. Am J Surg. 2008 Aug;196(2):252-64. https://doi.org/10.1016/j.amjsurg.2007.11.011 PMid:18466866
Khan I, Panda N, Banerjee M, Das R. Epidemiological factors in gall bladder cancer in eastern India-a single centre study. Indian J Surg Oncol. 2013 Mar;4(1):67-72. https://doi.org/10.1007/s13193-012-0203-x. Epub 2012 Dec 22. PMid:24426702 PMCid:PMC3578539
Zou ZY, Yan J, Zhuge YZ, Chen J, Qian XP, Liu BR. Multidisciplinary collaboration in gallbladder carcinoma treatment: A case report and literature review. Oncol Lett. 2016 Oct;12(4):2696-2701. https://doi.org/10.3892/ol.2016.5020. Epub 2016 Aug 16. PMid:27698845 PMCid:PMC5038553
Vijayakumar A, Vijayakumar A, Patil V, Mallikarjuna MN, Shivaswamy BS. Early diagnosis of gallbladder carcinoma: an algorithm approach. ISRN Radiol. 2012 Oct 18;2013:239424. https://doi.org/10.5402/2013/239424 PMid:24959553 PMCid:PMC4045520
Malka D, Fartoux L, Rousseau V, Trarbach T, Boucher E, Fouchardiere CDL, Faivre SJ, Viret F, Blanc J-F, Assenat E, Hammel P, Louvet C, Wichert GV, Ducreux M, Rosmorduc O, Pignon J-P, Greten TF. Gemcitabine and oxaliplatin (GEMOX) alone or in combination with cetuximab as first-line treatment for advanced biliary cancer: Final analysis of a randomized phase II trial (BINGO). Journal of Clinical Oncology. 2012;30:4032-4032. https://doi.org/10.1200/jco.2012.30.15_suppl.4032
Tairo-Cerron T, Paredes-Orue R, Moreno-Loaiza O. Frequency and characteristics of gallbladder cancer at a referral hospital in southern Peru, 2009-2014: a descriptive study. Medwave. 2018 Mar 26;18(2):e7184. Spanish, English. https://doi.org/10.5867/medwave.2018.02.7184 PMid:29624571
Löhe F, Meimarakis G, Schauer C, Angele M, Jauch KW, Schauer RJ. The time of diagnosis impacts surgical management but not the outcome of patients with gallbladder carcinoma. Eur J Med Res. 2009 Aug 12;14(8):345-51. doi: 10.1186/2047-783x-14-8-345. PMID: 19666394; PMCID: PMC3352165. https://doi.org/10.1186/2047-783X-14-8-345 PMid:19666394 PMCid:PMC3352165
Published
How to Cite
Issue
Section
Copyright (c) 2020 International Journal of Clinical Research
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.